Exercise News and Research

Latest Exercise News and Research

ASH wins six Aster Awards for excellence in healthcare marketing and advertising

American Specialty Health Incorporated, a national health and wellness organization, recently announced that it had won four Gold and two Silver Aster awards for excellence in healthcare marketing and advertising. The Aster Awards, one of the largest national competitions of its kind, is hosted by Marketing Healthcare Today Magazine and Creative Images, Inc.

1 Jun 2010

Akela Pharma fourth-quarter consolidated net loss increases to $14.1M

Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today announced its financial results for the three months and year ended December 31, 2009.

1 Jun 2010

Preparation reduces winter sports injuries

During winter those who are active need to prepare for the cold conditions or risk injuries, warns Sports Medicine Australia.

31 May 2010

Women unaware of their heart disease risk: Report

The Australian Institute of Health and Welfare has come up with results of their study funded by the National Heart Foundation that warns Australian women of their heart disease risk. It says that heart disease is the leading killer of Australian women and most women (eight out of ten) think that heart disease kills only “old men”.

31 May 2010

Elbit Imaging reports NIS 136 million loss attributable to equity holders for first-quarter 2010

Elbit Imaging Ltd. announced today its results for the first quarter of 2010.

31 May 2010

Celladon announces 6-month data from Phase 2 clinical trial of MYDICAR in advanced heart failure patients

Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that six-month data from its Phase 2 clinical trial of MYDICAR® show improvements in clinical outcomes and disease markers in advanced heart failure patients treated with the genetically targeted enzyme replacement therapy.

31 May 2010

Targeted Genetics's partner Celladon presents Phase II trial data with MYDICAR at Heart Failure Congress 2010

Targeted Genetics Corporation announced that its partner, Celladon Corporation, presented full data today that show the first Phase II trial with MYDICAR® for the treatment of advanced heart failure has met its primary safety and efficacy endpoints, as prospectively defined in the Phase II trial protocol.

31 May 2010

Secretary of Health commends two Allegheny County schools for commitment to exercise every day

Secretary of Health Everette James today visited the Avonworth and Mt. Royal middle schools in Allegheny County to commend students and teachers for their yearlong commitment to exercising for 30 minutes every school day.

29 May 2010

The Extra Gear founder earns distinction of Certified Consultant

Dana Blackmer, Ph.D., a resident of Richmond, has become one of the region's only professionals to earn the distinction of Certified Consultant by the Association for Applied Sport Psychology, the leading organization of sport and exercise psychology.

29 May 2010

University of Bath receives funding to launch major study of the scrum

The University of Bath has received funding from the International Rugby Board to launch a major study of the scrum that will that drive best practice player welfare policy in this critical area of the game.

29 May 2010

Advances in cancer care help people diagnosed with cancer survive the disease

Ed Gardella, a police officer for 31 years, thought he was pretty tough. But then the 70-year old Worcester, Mass. resident was diagnosed with esophageal cancer. "You never forget that moment, where you were that moment you were told you have cancer," said Gardella. "I never thought I was a particularly brave man, nor did I think I was a coward. I was a police officer, a chief of police, but this disease brings everyone to their knees — no one is tougher than cancer."

29 May 2010

Victhom attributes 99.6% decrease in first-quarter revenues to transfer of development activities to Ossur

Victhom Human Bionics Inc. today reported its first quarter 2010 financial results.

29 May 2010

Children watch more television if parents do

Children are more likely to watch high levels of television if their parents do, but parents do not need to be physically active to help their children to be active, a new study has found.

28 May 2010

Neptune's revenues increased by 8% for fiscal year ended February 28, 2010

Neptune Technologies & Bioressources Inc. today reports its consolidated financial results for the fiscal year ended February 28, 2010, announces the implementation of a shareholder rights plan and provides fiscal year highlights.

28 May 2010

Consistent consumption of alcohol contributes to high blood pressure

High blood pressure is a leading cause of deaths in the world. Apart from millions with diagnosed hypertension, still many others are borderline hypertensive. High blood pressure increases the risk of a person to develop cardiovascular diseases, kidney problems, heart attack and even a stroke. One of the major contributors to high blood pressure is the consistent consumption of alcohol. Regular alcohol drinkers increase the risks of elevated blood pressure because it affects the normal functioning of the body by reversing what it needs to remain healthy.

28 May 2010

Amgen announces European approval of Prolia

Amgen Inc. today announced that the European Commission (EC) has granted marketing authorization for Prolia® (denosumab) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures.

28 May 2010

Uroplasty reports strong sales growth for Macroplastique in fourth-quarter 2010

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the fourth fiscal quarter and full year ended March 31, 2010. The results were highlighted by continued strong U.S. sales growth for Macroplastique and a reduction in operating and net loss compared to the prior year.

28 May 2010

Salix Pharmaceuticals to sell $300 million of 2.75% convertible senior notes due 2015

Salix Pharmaceuticals, Ltd. today announced that it has entered into an agreement to sell $300 million aggregate principal amount of its 2.75% convertible senior notes due 2015. In addition, Salix has granted the underwriters an overallotment option to purchase up to an additional $45 million aggregate principal amount of notes on the same terms and conditions.

28 May 2010

Salix Pharmaceuticals announces $200 million convertible senior notes offering

Salix Pharmaceuticals, Ltd. today announced that it intends to offer, subject to market and other conditions, $200 million aggregate principal amount of its convertible senior notes due 2015 under an automatically effective shelf registration statement on file with the Securities and Exchange Commission. Salix also expects to grant the underwriters an overallotment option to purchase up to an additional $30 million aggregate principal amount of notes on the same terms and conditions.

27 May 2010

UCSF research shows brief exercise buffers the effects of stress-induced cell aging

Exercise can buffer the effects of stress-induced cell aging, according to new research from UCSF that revealed actual benefits of physical activity at the cellular level.

27 May 2010

Exercise News and Research

Latest Exercise News and Research

ASH wins six Aster Awards for excellence in healthcare marketing and advertising

Akela Pharma fourth-quarter consolidated net loss increases to $14.1M

Preparation reduces winter sports injuries

Women unaware of their heart disease risk: Report

Elbit Imaging reports NIS 136 million loss attributable to equity holders for first-quarter 2010

Celladon announces 6-month data from Phase 2 clinical trial of MYDICAR in advanced heart failure patients

Targeted Genetics's partner Celladon presents Phase II trial data with MYDICAR at Heart Failure Congress 2010

Secretary of Health commends two Allegheny County schools for commitment to exercise every day

The Extra Gear founder earns distinction of Certified Consultant

University of Bath receives funding to launch major study of the scrum

Advances in cancer care help people diagnosed with cancer survive the disease

Victhom attributes 99.6% decrease in first-quarter revenues to transfer of development activities to Ossur

Children watch more television if parents do

Neptune's revenues increased by 8% for fiscal year ended February 28, 2010

Consistent consumption of alcohol contributes to high blood pressure

Amgen announces European approval of Prolia

Uroplasty reports strong sales growth for Macroplastique in fourth-quarter 2010

Salix Pharmaceuticals to sell $300 million of 2.75% convertible senior notes due 2015

Salix Pharmaceuticals announces $200 million convertible senior notes offering

UCSF research shows brief exercise buffers the effects of stress-induced cell aging

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exercise News and Research

Latest Exercise News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in